Invention Grant
- Patent Title: Therapeutic combination for cancer treatment
- Patent Title (中): 癌症治疗的治疗组合
-
Application No.: US14124326Application Date: 2012-06-11
-
Publication No.: US09532984B2Publication Date: 2017-01-03
- Inventor: Stephen T. Gately
- Applicant: Stephen T. Gately
- Applicant Address: US AZ Phoenix
- Assignee: The Translational Genomics Research Institute
- Current Assignee: The Translational Genomics Research Institute
- Current Assignee Address: US AZ Phoenix
- Agency: Booth Udall Fuller, PLC
- Agent Rodney J. Fuller
- International Application: PCT/US2012/041924 WO 20120611
- International Announcement: WO2012/171015 WO 20121213
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K31/473 ; A61K31/155 ; A61K31/4706 ; A61K31/4439 ; A61K31/519 ; A61K45/06
Abstract:
This invention relates to a synergistic pharmaceutical combination of glucose lowering drugs and autophagy inhibitors, kits containing such combinations, and methods of using such combinations to treat subjects suffering from cancers carrying a specific KRAS mutation. This invention also relates to a theranostic method for cancer treatment.
Public/Granted literature
- US20140113930A1 THERAPEUTIC COMBINATION FOR CANCER TREATMENT Public/Granted day:2014-04-24
Information query
IPC分类:
